Error: Could not add to watchlist. X

Pharmacyclics Inc

+ Watchlist
PCYC:US
Acquired
PCYC:US was acquired by ABBV:US
261.25
USD
As of 20:10:00 ET on 05/22/2015.
Volume
1,953,837
52Wk Range
88.45 - 261.68
Current P/E Ratio (TTM)
267.24
Earnings per Share (USD) (TTM)
0.98
Market Cap (b USD)
20.137
Shares Outstanding (m)
77.079
Price/Sales (TTM)
24.22
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.
ADDRESS
995 East Arques Avenue
Sunnyvale, CA 94085-4521
United States
PHONE
1-408-774-0330
  • Robert W Duggan "Bob"
    Chairman/CEO
  • Manmeet Soni
    CFO/Treasurer
  • Mahkam Zanganeh "Maky"
    Chief Operating Officer
  • Shawn Cline Tomasello
    Chief Commercial Officer
  • Jesse McGreivy
    Chief Medical Officer
Show More